Abstract
The place of asparaginase in the strategy of acute leukemia treatment has not yet been defined because experience with this agent is too recent. Thus we present our own results, despite the very small number of patients (14 cases). These results seem highly significant, in so far as asparaginase, being in short supply, was strictly reserved for patients who had previously proved to be resistant to different antimitotic drugs.
With the assistance of B. Lerche and M. T. Caulier.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson, R. H., Fabra, S.: Antitumor activity and other biologic properties of L-asparaginase. A review. Cancer Chemother. Rep. 52, 617–626 (1968).
Bernard, J., Boiron, M., Jacquillat, C., Weil, M., Najean, Y., Thomas, M.: Traitement des leucémies aiguës lymphoblastiques de première atteinte par une association de Prednisone-Vincristine-Rubidomycine. Path. Biol. 15, 919–920 (1967).
Boiron, M., Jacquillat, C., Weil, M., Tanzer, J., Bernard, J.: L-asparaginase. Presse méd. 76, 2099–2101 (1968).
— Bilan de L-asparaginase. Journées d’Hématologie, Paris, Octobre 1969.
Broome, J. D.: Factors which may influence the effectiveness of L-asparaginase as tumor inhibitors. Brit. J. Cancer 22, 595–602 (1968).
Henderson, E. S.: Treatment of acute leukemia. Seminars in Hematology 6, 271 (1969).
Hill, J. M., Roberts, J., Loeb, E., Khan, A., MacLellan, A., Hill, R.: L-asparaginase therapy for leukemia and other malignant neoplasms: remission in human leukemia. J. Amer. med. Ass. 202, 882–888 (1967).
Jacquillat, C., Weil, M., Boiron, M.: La méthode de réinduction dans le traitement des leucémies aiguës. Actual. Hémat. deuxième série. Paris: Masson 1968, pp. 12–19.
Mathé, G. et coll.: Essai de traitement de la leucémie aiguë lymphoblastique par la L-asparaginase. Presse méd. 77, 461 (1969).
Oettgen, H. F., Old, L. J., Boyse, E. A., Campbell, H. A., Philips, F. S., Clarkson, B. D., Tallal, L., Leeper, R. D., Schwartz, M. K., Kim, J. H.: Inhibition of leukemias in man by L-asparaginase. Cancer Res. 27, 2619–2631 (1967).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Springer-Verlag Berlin • Heidelberg
About this chapter
Cite this chapter
Goudemand, M., Bauters, F. (1970). Clinical Trials of Asparaginase in Chemotherapy-Resistant Acute Leukemias. In: Grundmann, E., Oettgen, H.F. (eds) Experimental and Clinical Effects of L-Asparaginase. Recent Results in Cancer Research, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-99984-0_35
Download citation
DOI: https://doi.org/10.1007/978-3-642-99984-0_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-99986-4
Online ISBN: 978-3-642-99984-0
eBook Packages: Springer Book Archive